Interventional Cardiology News and Research

RSS

OpSens Announces SavvyWire™ Used During Two Live Cases at CRT Conference

Quebec City, Quebec, February 28, 2023 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, is pleased to announce the inaugural two SavvyWire live case broadcasts occurred on Monday, February 27, 2023, during the Cardiovascular Research Technologies (CRT) conference.

From OpSens Medical 1 Mar 2023

Morristown Medical Center reaches significant milestone of performing over 4,000 TAVR

Morristown Medical Center's Gagnon Cardiovascular Institute's structural heart program reached a significant milestone of performing over 4,000 transcatheter aortic valve replacement (TAVR) procedures with well over 650 in 2022 alone.

10 Feb 2023

Cedars-Sinai experts to present innovative heart research data during AHA Scientific Sessions 2022

During American Heart Association Scientific Sessions 2022, Prominent Cedars-Sinai Cardiologists, Cardiothoracic Surgeons and Interventionalists Available for Interviews

3 Nov 2022

American Heart Association and Cardiovascular Research Foundation join forces to produce joint education programs

Two leaders in cardiovascular disease science, research and education, the American Heart Association (Association) and the Cardiovascular Research Foundation (CRF), are joining forces to strengthen and expand educational opportunities focused on advancing the latest research in cardiovascular disease and interventional therapies.

15 Aug 2022

Study highlights the need for liver cirrhosis patients to be educated on hepatic venous pressure gradient

Just like the hypertension that people develop when their blood pressure increases, the increase of blood pressure in the main vein that supplies blood to the liver, called the portal vein, is also a dangerous situation.

31 May 2022

New analysis finds increase in success and efficiency of chronic total occlusion percutaneous coronary intervention

A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion Intervention; www.progresscto.org), an international multi-center registry of chronic total occlusion (CTO) percutaneous coronary intervention (PCI), was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

20 May 2022

Study finds no difference in survival between patients treated with paclitaxel drug-coated devices and non-DCDs

New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD) study were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

20 May 2022

SCAI releases position statement on best practices for clinical proctoring of new technologies and techniques

Today, the Society for Cardiovascular Angiography & Interventions (SCAI) released an official position statement aimed at providing recommendations to minimize the potential risks involved with medical proctoring. The document, "SCAI Position Statement on Best Practices for Clinical Proctoring of New Technologies and Techniques," was published today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), the official scientific publication of SCAI.

31 Mar 2022

New expert consensus on sex-specific considerations in myocardial revascularization released

A newly released expert consensus statement on sex-specific considerations in myocardial revascularization aims to summarize available literature on myocardial revascularization in women and identify important gaps in evidence.

6 Feb 2022

Trial finds similar five-year outcomes with transcatheter or surgical aortic valve replacement

New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality or stroke between patients at intermediate surgical risk who had transcatheter aortic valve replacement (TAVR) or surgery.

8 Nov 2021

Some immune checkpoint inhibitors can cause serious arrhythmias and myocarditis

Immune checkpoint inhibitors (ICIs) have transformed cancer care by unleashing T-cells to fight tumors, but they can cause serious cardiotoxicities including myocarditis. ICI-induced myocarditis represents a new clinical syndrome because of the novelty and considerable usage of ICIs.

7 Nov 2021

World-renowned expert to lead pediatric cardiology division at Washington University School of Medicine

Andrew C. Glatz, MD, an internationally recognized expert in pediatric interventional cardiology, has been selected to lead the Division of Pediatric Cardiology in the Department of Pediatrics at Washington University School of Medicine in St. Louis.

30 Oct 2021

Catheter-based aortic valve replacement can help a broad range of heart patients, study shows

Aortic stenosis, a narrowing of the aortic valve opening that restricts blood flow through the heart, is one of the most common and serious heart valve diseases.

21 Sep 2021

Study finds no difference in physician-patient gender concordance

While some studies suggest female patients treated by female physicians have better outcomes, there does not appear to be a relationship between operator and patient gender and outcome in patients undergoing coronary angioplasty or stenting. T

26 May 2021

Randomized clinical trials compare effects of coronary revascularization versus medical therapy alone

A rigorous meta-analysis of randomized clinical trials (RCTs) that compared the effects of medical therapies alone with medical therapies plus revascularization in patients with stable ischemic heart disease (SIHD) was presented at EuroPCR on May 18, 2021.

19 May 2021

Novel technology can be effective non-surgical treatment option for congenital heart disease patients

New study results validate the effectiveness of the Medtronic Harmony™ transcatheter pulmonary valve (TPV) system for patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR).

30 Apr 2021

Analysis reveals benefits of using longer covered stent in patients with rare congenital heart disease

An analysis of a new international registry reveals benefits of using a longer covered stent for interventional procedures in congenital heart disease patients with Sinus Venosus Atrial Septal Defect (SVASD).

30 Apr 2021

Abbott’s new imaging platform powered by Ultreon 1.0 Software launches in Europe

Abbott today announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe.

30 Apr 2021

Study reports 70% decline in heart attack patients who sought care during the pandemic

Results from a retrospective observational study, presented today at Society for Cardiovascular Angiography and Interventions 2021 Virtual Scientific Sessions, reveal a 70% decline in the number of patients presenting with acute myocardial infarction (AMI) during April 2020 compared to April 2019.

29 Apr 2021

New device minimizes hemostasis time for patients receiving cardiac catherization

A new study reveals the use of a potassium ferrate hemostatic patch (PFHP) reduces the time to hemostasis for patients receiving cardiac catherization. The findings indicate a faster approach to removing the compression band used during the procedure, without compromising safety.

29 Apr 2021

Interventional Cardiology News and Research

OpSens Announces SavvyWire™ Used During Two Live Cases at CRT Conference

Morristown Medical Center reaches significant milestone of performing over 4,000 TAVR

Cedars-Sinai experts to present innovative heart research data during AHA Scientific Sessions 2022

American Heart Association and Cardiovascular Research Foundation join forces to produce joint education programs

Study highlights the need for liver cirrhosis patients to be educated on hepatic venous pressure gradient

New analysis finds increase in success and efficiency of chronic total occlusion percutaneous coronary intervention

Study finds no difference in survival between patients treated with paclitaxel drug-coated devices and non-DCDs

SCAI releases position statement on best practices for clinical proctoring of new technologies and techniques

New expert consensus on sex-specific considerations in myocardial revascularization released

Trial finds similar five-year outcomes with transcatheter or surgical aortic valve replacement

Some immune checkpoint inhibitors can cause serious arrhythmias and myocarditis

World-renowned expert to lead pediatric cardiology division at Washington University School of Medicine

Catheter-based aortic valve replacement can help a broad range of heart patients, study shows

Study finds no difference in physician-patient gender concordance

Randomized clinical trials compare effects of coronary revascularization versus medical therapy alone

Novel technology can be effective non-surgical treatment option for congenital heart disease patients

Analysis reveals benefits of using longer covered stent in patients with rare congenital heart disease

Abbott’s new imaging platform powered by Ultreon 1.0 Software launches in Europe

Study reports 70% decline in heart attack patients who sought care during the pandemic

New device minimizes hemostasis time for patients receiving cardiac catherization

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News